CANDEL THERAPEUTICS, INC. (CADL) Free cash flow 2020–2025
CANDEL THERAPEUTICS, INC. (CADL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$38.9MFY2025 · since FY2020: -$10.5M → -$38.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.9M | -43.9% |
| FY2024 | -$27.0M | +22.1% |
| FY2023 | -$34.7M | -6.1% |
| FY2022 | -$32.7M | -36.0% |
| FY2021 | -$24.1M | -128.1% |
| FY2020 | -$10.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice